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From the Editor-in-Chief
The reason for this special supplement of the Journal is to inform readers of a scientific research
conference supported by the National Institutes of Health (NIH). The NIH Research Conference
Grant (R13) supports high quality scientific conferences in areas that are important to the NIH’s
mission and to the public health. We just received notification that the National Heart, Lung, and
Blood Institute (NHLBI) has approved the application for an international research conference en-
titled: "Clinical & Translational Research in Pneumonia: Defining a Research Agenda for Today
and Tomorrow". The conference will be held on Wednesday, May 24th and Thursday, May 25th,
2017 in the city of Washington, D.C., USA. In this supplement, I will describe the novel method-
ology that will be used during this research conference, the conference objectives, and some
general information regarding the conference.
A New Conference Paradigm
Current international medical conferences are good venues for
the transfer of knowledge from experts in the field to a general
audience of practitioners. On the other hand, opportunities for
researchers to have the appropriate time and setting to discuss
their current research and gain feedback and collaboration are
limited. Although virtual meetings allow investigators to interact,
the outcomes of these interactions are rarely equal to in-person
contact.
The existing paradigm for scientific conferences is to allow the
presenter approximately 45 minutes to outline a detailed descrip-
tion of her/his research including completed work that may have
been already published. This is traditionally followed by 15 min-
utes of questions focused on clarifying concepts from the presen-
tation.
In this conference we are challenging this existing paradigm. The
presentations will be more focused, last only 15-minutes, and ex-
clude detailed of previous literature of the topic. It will be fol-
lowed not by a question and answer session, but by a 15-minute
moderated brainstorming session. This brainstorming will allow
for a free flow of ideas from all of the experts. Some presentations
will focus on "defining the research agenda for today" and some
on "defining the research agenda for tomorrow."
Speakers in the module "defining the research agenda for today"
will have 15 minutes to present the most important aspects of
her/his active research activities with limited discussion of al-
ready published data and background information. The presen-
tation will be followed by a 15 minute moderated brainstorming
session to give expert feedback and to generate new ideas for col-
laboration.
Speakers in the module "defining the research agenda for tomor-
row" will have 15 minutes to present the most important research
gaps in a particular field of pneumonia. The presentation will
be followed by a 15 minute moderated brainstorming session to
generate pathways for resolution of current gaps.
Conference Objectives
The overall objective of the conference is to bring together the
pneumonia research community to provide a unique opportunity
to foster global clinical and translational research in the field of
pneumonia, influenza, and emerging respiratory pathogens.
To achieve this, the conference has the following objectives:
1. To foster an international research network in the field of
pneumonia, influenza, and emerging respiratory pathogens.
2. To expand and strengthen the existing research collabora-
tion among national and international investigators.
3. To recognize gaps in the knowledge of lung infections and
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to identify research pathways to fill these gaps.
4. To engage junior investigators in the field of lung infection
research.
Conference Directors
This research conference is chaired by Dr. Julio Ramirez, Profes-
sor of Medicine at the University of Louisville. The conference
co-chairs are Dr. Richard Wunderink, Professor of Medicine at
Northwestern University and Dr. Charles Feldman, Professor of
Pulmonology at the University of the Witwatersrand.
Conference Speakers
Speakers Representing Research Teams from the United
States
Richard Wunderink, MD
Professor of Medicine, Pulmonary and Critical Care,
Northwestern University
Chicago, USA
Michael S Niederman, MD
Professor of Clinical Medicine, Joan and Sanford I. Weill
Department of Medicine,
Weill Cornell University, New York, New York, USA
Thomas File, MD
Professor of Medicine,
Northeastern Ohio Universities,
Chief, Infectious Disease Service,
Summa Health System, Akron, USA
Julio Ramirez, MD
Professor of Medicine,
Chief, Division of Infectious Diseases,
University of Louisville, Louisville, USA
Nathan C. Dean, MD
Professor of Medicine,
Chief, Pulmonary and Critical Care,
Intermountain Medical Center,
University of Utah, Salt Lake City, USA
Antonio Anzueto, MD
Professor of Medicine,
Chief, Pulmonary Section, Audie L Murphy Veterans
Hospital
University of Texas, San Antonio, USA
Marcos Restrepo, MD
Associate Professor Medicine, Director Intensive Care Unit,
Audie L Murphy Veterans Hospital
University of Texas, San Antonio, USA
Mark Metersky, MD
Professor of Medicine,
Director, UConn Center for Bronchiectasis Care,
Director, Pulmonary and Critical Care Fellowship Program,
University of Connecticut, Farmington, Connecticut, USA
Charles Dela Cruz, MD
Associate Professor of Medicine,
Director, Yale Center for Pulmonary Infection Research and
Treatment (CPIRT),
Yale University, New Haven, Connecticut, USA
Jose Bordon, MD
Assistant Professor,
Georgetown University;
Chief, Section of Infectious Diseases,
Providence Hospital, Washington DC, USA
Daniel Musher, MD
Distinguished Service Professor of Medicine-Infectious
Disease,
Baylor College of Medicine, Houston, Texas, USA
Lis Caler, Ph.D.
Program Director, Division of Lung Diseases,
National Heart, Lung, and Blood Institute,
NIH, Bethesda, Maryland, USA
Barbara Jones, MD
Assistant Professor, Pulmonary/Critical Care Medicine
Salt Lake City Veterans Affairs Medical Center
University of Utah, Salt Lake City, Utah, USA
Speakers Representing Research Teams from Other Countries
Francesco Blasi, MD
Professor of Respiratory Medicine,
Vice-chairman, Department of Pathophysiology and
Transplantation,
Università degli Studi di Milano, Milan, Italy
Tobias Welte, MD
Professor, Pulmonary Medicine,
Head, Department of Pulmonary & Infectious Diseases,
Hannover University, Hannover, Germany
Antoni Torres, MD
Professor of Medicine, Director of Institut Clínic de
Pneumologia i Cirurgia Toràcica Hospital Clínic de
Barcelona, Barcelona, Spain
Jordi Rello, MD
Associate Professor of Medicine, Chief of Critical Care, Vall
d’Hebron University Hospital, University of Barcelona,
Barcelona, Spain
James Chalmers, MD
Lecturer in Respiratory Medicine, Department of
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Respiratory Medicine, Ninewells Hospital and Medical
School, Dundee, Scotland
Stefano Aliberti, MD
Department of Health Science, University of Milan-Bicocca,
Respiratory Dept, AO San Gerardo, Monza, Italy
Rosario Menedez, MD
Chief, Pneumology Department, Hospital La Fe, Valencia,
Spain
Grant Waterer, MD
Professor of Medicine, Medical Co-Director, Service 4, Royal
Perth Hospital, University of Western Australia, Perth,
Australia
Charles Feldman, MD
Professor of Pulmonology, Chief Physician, Charlotte
Maxeke, Johannesburg Academic Hospital, University of
the Witwatersrand, Johannesburg, South Africa
Carlos Luna, MD
Professor of Medicine, Chief Pulmonary Hospital Clínicas,
Universidad de Buenos Aires, Buenos Aires, Argentina
Yuichiro Shindo, MD
Associate Professor of Medicine, Department of Respiratory
Medicine, Nagoya University, Nagoya, Japan
Conference Dates, Hours, and Location
The research conference will take place on Wednesday, May 24th
from 9AM until 6PM and on Thursday, May 25th from 8AM until
4PM. The conference will take place at The Loft at 918 F Street
NW, Washington, D.C. 20004.
Conference Participants & Registration
This conference is open to all healthcare workers interested in the
field of pneumonia research. If you are interested in participating
in this conference, please register using our online form, or email
Kimberley Buckner at kfbuck01@louisville.edu requesting to be
registered as a conference participant.
Virtual Participant
We are planning to offer this research conference on a free on-
line platform to allow interested investigators to be a virtual par-
ticipant in the conference. For more information please regis-
ter using our online form, or email Kimberley Buckner at kf-
buck01@louisville.edu requesting to be registered as a confer-
ence virtual participant.
Conference Proceedings
The University of Louisville Journal of Respiratory Infections will
offer a published conference proceedings supplement summariz-
ing the current and future areas of research from each of the
participating research centers, which will be available at http:
//louisville.edu/jri.
If you have any further questions regarding this research confer-
ence you can contact me at: j.ramirez@louisville.edu
Thank you, and I hope to see you in Washington, DC.
Julio A. Ramirez, MD
University of Louisville
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